Cargando…
Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1
The monarchE Cohort 1 patient population was enrolled based on high-risk clinicopathological features that can easily be identified as part of routine clinical breast cancer evaluation. Efficacy data from Cohort 1 demonstrate substantial evidence of benefit for adjuvant abemaciclib+ET in patients wi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847542/ https://www.ncbi.nlm.nih.gov/pubmed/36342342 http://dx.doi.org/10.1093/oncolo/oyac234 |
_version_ | 1784871478462775296 |
---|---|
author | Toi, Masakazu Boyle, Frances Im, Young-Hyuck Reinisch, Mattea Molthrop, David Jiang, Zefei Wei, Ran Sapunar, Francisco Grimes, Brenda R Nabinger, Sarah Cassidy Johnston, Stephen R D |
author_facet | Toi, Masakazu Boyle, Frances Im, Young-Hyuck Reinisch, Mattea Molthrop, David Jiang, Zefei Wei, Ran Sapunar, Francisco Grimes, Brenda R Nabinger, Sarah Cassidy Johnston, Stephen R D |
author_sort | Toi, Masakazu |
collection | PubMed |
description | The monarchE Cohort 1 patient population was enrolled based on high-risk clinicopathological features that can easily be identified as part of routine clinical breast cancer evaluation. Efficacy data from Cohort 1 demonstrate substantial evidence of benefit for adjuvant abemaciclib+ET in patients with HR+, HER2− early breast cancer at high risk of recurrence (ClinicalTrials.gov: NCT03155997 [monarchE]). |
format | Online Article Text |
id | pubmed-9847542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98475422023-01-20 Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 Toi, Masakazu Boyle, Frances Im, Young-Hyuck Reinisch, Mattea Molthrop, David Jiang, Zefei Wei, Ran Sapunar, Francisco Grimes, Brenda R Nabinger, Sarah Cassidy Johnston, Stephen R D Oncologist Brief Communication The monarchE Cohort 1 patient population was enrolled based on high-risk clinicopathological features that can easily be identified as part of routine clinical breast cancer evaluation. Efficacy data from Cohort 1 demonstrate substantial evidence of benefit for adjuvant abemaciclib+ET in patients with HR+, HER2− early breast cancer at high risk of recurrence (ClinicalTrials.gov: NCT03155997 [monarchE]). Oxford University Press 2022-11-07 /pmc/articles/PMC9847542/ /pubmed/36342342 http://dx.doi.org/10.1093/oncolo/oyac234 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Brief Communication Toi, Masakazu Boyle, Frances Im, Young-Hyuck Reinisch, Mattea Molthrop, David Jiang, Zefei Wei, Ran Sapunar, Francisco Grimes, Brenda R Nabinger, Sarah Cassidy Johnston, Stephen R D Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title_full | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title_fullStr | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title_full_unstemmed | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title_short | Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1 |
title_sort | adjuvant abemaciclib combined with endocrine therapy: efficacy results in monarche cohort 1 |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847542/ https://www.ncbi.nlm.nih.gov/pubmed/36342342 http://dx.doi.org/10.1093/oncolo/oyac234 |
work_keys_str_mv | AT toimasakazu adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT boylefrances adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT imyounghyuck adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT reinischmattea adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT molthropdavid adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT jiangzefei adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT weiran adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT sapunarfrancisco adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT grimesbrendar adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT nabingersarahcassidy adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 AT johnstonstephenrd adjuvantabemaciclibcombinedwithendocrinetherapyefficacyresultsinmonarchecohort1 |